South Carolina HCA Affiliate, Grand Strand Medical Center, is First in the Region with a Mazor Robotics Renaissance(R) Spine ...
August 30 2016 - 8:10AM
Mazor Robotics Ltd. (TASE:MZOR) (NASDAQGM:MZOR), a developer of
innovative guidance systems and complementary products, installed a
Renaissance® Guidance System at Grand Strand Medical Center in
Myrtle Beach, SC on July 6, 2016 and has since completed an initial
case series. Grand Strand is the second in the state of South
Carolina and the ninth HCA-affiliated facility to purchase a
Renaissance system. See how Renaissance works. "One of our main
goals is to help improve outcomes for our patients," said Mark
Sims, Chief Executive Officer for Grand Strand Medical Center.
"Adding the Renaissance technology to our spine surgery program
will elevate the level of quality care available to our community."
Grand Strand Medical Center is a 301-bed acute care hospital
serving residents of Horry and surrounding counties. The hospital
offers the only cardiac surgery program, neurosurgery program and
pediatric intensive care unit (PICU) in Horry and Georgetown
counties and is a designated Level II Trauma Center by DHEC and the
American College of Surgeons. "Now, thanks to Grand Strand
Medical Center, spine surgeons and their patients in the Myrtle
Beach area have access to our technology" said Mazor Robotics Inc.
CEO Christopher Prentice. "We believe in healing through innovation
and we look forward to Grand Strand Medical Center redefining the
standard of quality care."
About Mazor
Mazor Robotics (TASE:MZOR) (NASDAQGM:MZOR) believes in healing
through innovation by developing and introducing revolutionary
technologies and products aimed at redefining the gold standard of
quality care. Mazor Robotics Guidance Systems enable surgeons
to conduct spine and brain procedures in a precise manner. For more
information, please visit www.MazorRobotics.com.
Forward-Looking Statements This press release contains
forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995 and other securities
laws. Any statements in this release about future
expectations, plans or prospects for the Company, including
without limitation, statements regarding the benefits of
the Renaissance technology, and other statements
containing the words believes, anticipates, plans,
expects, will and similar expressions are forward-looking
statements. These statements are only predictions based on
Mazor's current expectations and projections about future
events. There are important factors that could cause Mazor's
actual results, level of activity, performance or achievements
to differ materially from the results, level of
activity, performance or achievements expressed or implied by
the forward-looking statements. Those factors include, but are
not limited to, the impact of general economic conditions,
competitive products, product demand and market acceptance
risks, reliance on key strategic alliances, fluctuations in
operating results, and other factors indicated in Mazor's filings
with the Securities and Exchange Commission (SEC) including
those discussed under the heading "Risk Factors" in Mazor's
annual report on Form 20-F filed with the SEC on May 2, 2016
and in subsequent filings with the SEC. For more details,
refer to Mazor's SEC filings. Mazor undertakes no obligation
to update forward-looking statements to reflect
subsequent occurring events or circumstances, or to changes in
our expectations, except as may be required by law.
CONTACT:Stephani Shipman
Marketing Communications Manager
Mazor Robotics
s.shipman@mazorrobotics-us.com
(407) 591-3461
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Mazor Robotics (NASDAQ:MZOR)
Historical Stock Chart
From Apr 2023 to Apr 2024